Press

ClearLight Media Resources

Logos, images, videos, collateral and more.

Fast Facts

  • Founded in 2015 by Karl Deisseroth MD, PhD
  • Early-stage private company backed by Wiegers and affiliates, Pivotal and KESA Partners
  • Experts at CLARITY Tissue Processing, thick tissue antibody staining, and Tru3D tissue analysis
  • Provides research use only lab services to pharmaceutical, biotechnology, and academic researchers
  • Developing next-generation tissue processing and image analysis platform to facilitate 3D analysis of preclinical and clinical models of disease

Company Overview

ClearLight Biotechnologies provides contract research and development services to pharmaceutical companies who seek to improve the efficacy of potential drug candidates. The company provides pharmaceutical, biotechnology, and academic researchers with CLARITY Tissue Clearing, 3D immunostaining, and Tru3D image analysis services. The company is developing an automated instrumentation platform based on the CLARITY lipid-clearing technique developed by Dr. Deisseroth and colleagues at Stanford University.

ClearLight Press Resources

Frequently used press resources including downloadable images, video, fast facts, logos, and more.

Image Usage Policy

While we don’t require prior approval for use of images and videos we do ask that you courtesy inform us of where and when you plan to use them. Use the embed codes or include the credit line on all photos and videos used, “Courtesy of ClearLight Biotechnologies.”  Please use the embed link or include this credit on the page you use any of these images or videos.

Brand and Style

Logos, usage, and more.

ClearLight Biotechnologies Logo and Brand Guide

Fully scalable vector files and usage guide. Illustrator compatible PDF.

ClearLight Biotechnologies
Download: EmbedPrintWeb
Embed Code:
ClearLight Biotechnologies
Download: EmbedPrintWeb
Embed Code:
ClearLight Biotechnologies
Download: EmbedPrintWeb
Embed Code:
ClearLight Biotechnologies
Download: EmbedPrintWeb
Embed Code:

Our Team

Dr. Sharla White

Director of Research and Development

  • Expert in CLARITY across different tissues
  • Diverse background brings perspective
  • Experience with various pilots and feasibility studies
  • Research focus areas:
    • cancer biology
    • immunotherapeutics
    • cancer immunology
    • tissue clearing technologies
    • cardiovascular diseases
    • vascular biology
    • Inflammation

LinkedIn

Press Resources Image of Director of Research and Development - Dr. Sharla White
Download: EmbedWeb
Dr. Sharla White and ClearLight Bio Lab Services Team - Press Resources
Download: EmbedWeb
ClearLight Bio Lab Services Team - Press Resources
Download: EmbedWeb
Members of ClearLight Biotechnologies Science Team - Press Resources
Download: EmbedWeb
ClearLight Biotechnologies - Dr. Sharla White - Press Resources
Download: EmbedWeb

Press Resources - Images and Videos

Image and video examples of immunostained tissues after CLARITY Tissue Clearing. #SeeMoreBiology

Selected Press Resources Images

Lung Carcinoma

DAPI (blue), pan-cadherin (green), CD8 (yellow), α-SMA (red)

Image of Lung Carcinoma immunostained with DAPI (blue), pan-cadherin (green), CD8 (yellow), α-SMA (red) - Press Resources from ClearLight
Download: EmbedPrintWeb

Human Tonsil

DAPI (blue), CD8 (yellow), pan-Cytokeratin (green), PD-L1 (red)

Human Tonsil Immunostained with DAPI (blue), CD8 (yellow), pan-Cytokeratin (green), PD-L1 (red) - Press Resources from ClearLight Biotechnologies
Download: EmbedPrintWeb

Human Tonsil

DAPI (blue), Ki67 (yellow), pan-Cytokeratin (green), CD3 (red)

Image of Human Tonsil immunostained with DAPI (blue), Ki67 (yellow), pan-Cytokeratin (green), CD3 (red) - Press Resources from ClearLight Biotechnologies
Download: EmbedPrintWeb

ClearLight Delivers

3D IHC Viewing Experiences

ClearLight Biotechnologies Delivers 3D IHC Viewing Experience - Press Resources
Download: EmbedPrintWeb

IHC In Your Hand

New insights await your discovery.

Image of Imagining New Possibilities with 3D IHC - Sphere - Press Resources
Download: EmbedPrintWeb

ClearLight Delivers

3D IHC Viewing Experiences

Image of 3D IHC Viewing Experience Giving New Insights to Researchers - Press Resources
Download: EmbedPrintWeb

Selected Press Resources Videos - Examples of 3D IHC

Download: Full Quaility .mp4 | Description

Video Loop 1:

A passively cleared and immunostained normal mouse brain (5 mm dia. x 1 mm thick) that has been stained with DAPI to identify individual cells, Lectin-DyLight 594 to identify vasculature, and Histone H3-Alexa Fluor 647, a chromatin marker.

Download: Full Quaility .mp4 | Description

Video Loop 2:

A vasculature-rich region of an inflamed human tonsil tissue that has been immunostained with CD4 to denote immune cells, such as monocytes, T helper cells, dendritic cells, and macrophages. Both alpha smooth muscle actin (α-SMA) and CD31, primarily an endothelial cell marker, were used to observe possible vasculature with some signal co-localization observed in certain vessels. Finally, the nuclear stain, DAPI, is shown to demonstrate all cells present in the tonsil tissue.

Download: Full Quaility .mp4 | Description

Video Loop 3:

An image of a Hep55 syngeneic mouse tumor, used to model hepatocellular carcinoma, that has been immunostained for pan-cytokeratin (pan-CK), CD163, CD68, and DAPI, a nuclear cell DNA marker. Pan-CK can be used to identify epithelial cells and denote tumor cells, while CD163 and CD68 can identify immune cells and macrophage-linage cells.

Download: Full Quaility .mp4 | Description

Video Loop 4:

An inflamed hyperplastic tonsil tissue immunostained to identify epithelial cells (pan-cytokeratin), proliferating cells (Ki-67), and T cells (CD3). DAPI, the nuclear counterstain, marks all cells present in the tissue.

Download: Full Quaility .mp4 | Description

Video Loop 5:

An inflamed human tonsil tissue stained with DAPI to clearly identified the individual cell nuclei present within the tissue. Both alpha smooth muscle actin (α-SMA) and CD31 were used to observe possible vasculature with some signal co-localization observed in certain vessels. CD45RO was used a marker to aid in the identification of regulatory T cells (Tregs).

Download: Full Quaility .mp4 | Description

Video Loop 6:

An inflamed human tonsil tissue stained with DAPI to clearly identified the individual cell nuclei present within the tissue. Both alpha smooth muscle actin (α-SMA) and CD31 were used to observe possible vasculature with some signal co-localization observed in certain vessels. CD20 is utilized as a pan-B cell marker and used identify B cells, and in rare cases can be found on some T cells.

Selected Press Resources Downloads

Drug Development

See where ClearLight fits into the Drug Development Process.

CLARITY Infographic

Learn more about the CLARITY Tissue Clearing Process.

Company Fact Sheet

Mission, fast facts, history, contacts, and more all on one page.

Director or Research and Development - Dr. Sharla White for Press Resources Page

How Can We Help You?

Should you require something more than the press resources on this page, we will be happy to assist you. Please direct any questions to JUG Marketing, at (657) 221-7128. If you’d like to be contacted directly, please fill out the form below and include specific media inquiry details.

    Creating Cures Community

    We applaud the research community and their involvement in the drug discovery and development process. These are the modern heroes who will create the cures of tomorrow for the diseases that impact human potential and decrease lifespan. Perhaps you are one. Join us.

    Previous Issues

    Analysis can be performed for select biomarkers, please contact us to find out if your target of interest is one of them. Imaging is currently performed on select fields of view instead of the entire sample.

    Submission Guidelines

    Tissue Sample Requirements: